Managing Gastrointestinal Side Effects Nausea, vomiting, constipation, and reflux are the leading causes of medication discontinuation and failure to titrate to an effective dose
We dove deep into multi-agonist combinations , next-generation tolerability , adaptive clinical trial design , and the untapped potential in emerging indications , including neurodegenerative disease from industry giants including Eli Lilly , AstraZeneca and Sanofi
Semaglutide is a GLP-1 agonist, mimicking the action of incretin hormones that play a role in your appetite and digestion
Trial dosing should not be copied for personal use
Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimers disease: results of a randomized, double-blind, placebo-controlled phase 2a study
Beyond medication alone, your provider can offer personalized guidance based on your health history, genetics (via Precision Peptide Genetic Test after month one), and lifestyle